By first separating mutant from nonmutant DNA sequences on the basis of their melting temperatures and then increasing the number of copies by highfidelity DNA amplification, we have developed a method that allows observation of point mutations in biological samples at fractions at or above 10-6. Using this method, we have observed the hotspot point mutations that lie in 100 base pairs of the mitochondrial genome in samples of cultured cells and human tissues. To date, 19 mutants have been isolated, their fractions ranging from 4 x 10-4 down to the limit of detection. We performed specific tests to determine if the observed signals were artefacts arising from contamination, polymerase errors during PCR or DNA adducts created during the procedure. We also tested the possibilities that DNA replication mismatch intermediates, or endogenous DNA adducts that were originally present in the cells, were included with true mutants in our separation steps and converted to mutants during PCR. We show that while most of the mutants behave as double-stranded point mutants in the cells, some appear to arise at least in part from mismatch intermediates or cellular DNA adducts. This technology is therefore sufficient for the observation of the spectrum of point mutations in human mitochondrial DNA and is a tool for discovering the primary causes of these mutations.
INTRODUCTION
From Mendel to the present era, the study of mutagenesis required recognition of a phenotypic change in cells or organisms. Recently, approaches to detecting rare (<10-4) mutations in DNA based on genotype rather than phenotype have been developed. For example, allele specific PCR (1, 2) , ligase chain reaction (3) (4) (5) (6) or high efficiency restriction digestion (7-10) permit detection of single base pair changes in known sequences with scanning ranges from 1 to 6 base pairs (bp).
In order to extend the scanning range of genotypic approaches, we previously coupled high-fidelity PCR with denaturing-gradient gel electrophoresis, DGGE, which was developed by Fischer and Lerman (11) building on the studies of cooperative equilibria in macromolecules pioneered in statistica! mechanics (12) (13) (14) . This allowed us to see point mutations in DNA isomelting domains of -100 bp in cultured human cells (15, 16) .
In that work we were obliged to enrich for mutants in the hprt gene by phenotypic selection (6-thioguanine resistance). This selection increased the mutant fraction from 10--7 to 10-3, a detectable level for our high-fidelity PCR/DGGE procedure. Since phenotypic selection based on selective growth of mutant cells cannot be applied to human tissues, we continued to develop technology which separated mutant sequences from the vast excess of normal sequences by physicat or chemical differences.
Recently, we have taken advantage of capillary gel electrophoresis (17) to create a separation method called 'constant denaturant capillary electrophoresis' (CDCE) (18) . Separation by CDCE enabled us to measure mutant fractions as low as 10-6 in model reconstruction experiments with mixtures of PCR fragments (7) . We calculated that a detection limit of -10-6 would allow us to see hotspots in human mitochondria! DNA if they occurred at a mutation rate that is 20 times higher than nuclear point mutations, as has been estimated based on studies of evolution (19) (20) (21) (22) . Also, mitochondrial DNA is present as a few hundred to thousands of copies per ce!!, which reduces the size of the tissue sample and the amount of total DNA that must be handled to obtain statistically reproducible observations (23) .
As reported herein, the detection limit achieved was indeed sufficient to observe the human mitochondrial point mutational spectrum for our 100 bp target sequence in human cells and tissues. Key to this report are the series of tests in which we explored the possibility that our observations were artefacts generated by our procedures. While we find that the methodology described is sufficient for identifying and measuring hotspot point mutations in mitochondrial DNA, further technical improvements are needed to achieve our goal of measuring mutational spectra in nuclear DNA where mutant fractions and the number of target sequence copies per cell are both lower.
MATERIALS AND METHODS

Human cells and tissues
TK6 cells (24) were maintained in exponential growth as spinner cultures by daily dilution with RPMI-1640 media (Gibco BRL, Grand Island, NY) supplemented with 10% horse serum (Gibco BRL) at densities not exceeding 106 cells/ml. Brush bronchoscopy samples of human lung epithelial cells were obtained through collaboration with Dr M. Utell and Dr M. Frampton of the University of Rochester Medical Center. Cells, tissue and DNA samples were stored at -70°C.
DNA isolation and restriction digestion
DNA was isolated from suspended cells or macerated tissue by digestion with proteinase K (1 mg/mi) and RNAse A (0.1 mg/mi) in 0.5% SDS followed by ethanol precipitation of DNA. DNA prepared in this way was easily restricted and amplified. The method provided high DNA yields from 105 to 109 cultured cells or from milligrams to grams of tissue. The DNA was digested with RsaI, which recognizes base pairs 10 009-10 012 of the mitochondrial genome, and Ddel, which recognizes base pairs 10 227-10 231 (New England Biolabs, Beverly, MA) at 2 Uilig DNA, ovemight. To prevent contamination with enriched mutants, the first stages of DNA isolation and mutant purification were carried out in a separate clean room.
Constant denaturant gel electrophoresis (CDGE)
CDGE gels were 8% acrylamide, 1/40 bis-acrylamide, TAE (40 mM Tris-acetate, 1 mM EDTA), 0.4 mm thick. The gels were submerged in a tank containing TAE heated to a precisely selected temperature around 70°C. As the temperature is increased, the electrophoretic mobility of a DNA fragment with a biphasic melting profile decreases following a sigmoid curve. We selected a temperature at the midpoint of the sigmoid curve of the wild-type fragment for our experiments in order to ensure the best separation of both high and low Tm mutants from the wild-type. Samples of 4-6 jiJ of a restriction digestion were loaded and separated for 2 h at 10 V/cm.
Fluorescein-labeled markers and samples were separated in altemating parallel lanes. The markers were a mixture of PCR amplified hprt exon 3 wild-type and mutant homoduplexes and heteroduplexes with melting temperatures similar to those of the mitochondrial DNA mutants to be detectecl. One lane of each gel contained a second marker which was the wild-type target mitochondrial sequence with an altered high melting domain primer (for sequence, see Materials and Methods: High-fidelity PCR). The melting behavior of this sequence was indistinguishable from that of the normal wild-type sequence, but it could not be amplified with the primers used for subsequent PCR. This primer was designed as such to avoid contamination of the tissue samples (the number of target sequence copies in a marker lane is three orders of magnitude higher than in the sample lane). The marker bands were visualized by illuminating the gel with the 488 nm argon laser used for CDCE (see below) and marked while viewing the gel through a 520 nm low pass glass filter (Oriel, Stratford, CT). The relative positions of the markers provide information on the exact position to which the desired mitochondrial mutants migrated in the gel. The portions of the gel below and above the marker wild-type band were cut so as to include the range of mobilities of most mutant fragments.
The gel slices were finely ground between two glass slides and transferred into 1.5 ml test tubes containing 200 III of 200 mM NaCl. DNA was eluted by shaking for 20 min at 50°C, 1300 min-1. Gel Officies were spun down, and the supematant was collected.
The DNA was precipitated with 2 vol of ethanol and dissolved in -15 ffl of water.
Constant denaturant capillary electrophoresis (CDCE)
Our CDCE instrument has been described previously (17, 18, 25) . Briefly, electrophoresis was performed in 30 cm long 75 fim I.D. capillaries. A portion of the capillary was heated by a water jacket connected to a constant temperature circulator. The jacket was positioned 5 cm from the injection end of the capillary. The length of the jacket was 5 cm for the enrichment of heteroduplexes and 15 cm for high resolution CDCE. The temperature of the water jacket was -65 °C. The precise temperature to be used in a particular experiment and the time of fraction collection was determined in test runs with appropriate standards.
In this study, the CDCE instrument used for identification of mutants has been improved by adding a two wavelength detector. To detect DNA, the capillary was illuminated by a 515 nm argon laser and emitted light was collected at a right angle by a microscope objective. For two-channel detection of two fluorophores, collected light was split and directed into two detectors through appropriate sets of filters. For fluorescein, a combination of a 540 nm bandpass and a 530 nm long pass filter was used; for tetramethylrhodamine (TMR), a single 580 nm bandpass filter was employed. The signals from the photomultipliers were recordecl by a computerized data acquisition system.
The inner surface of the capillaries was coated with linear polyacrylamide chains. The coating procedure was adapted from a methodology published by Hjerten (26) . Capillaries were treated with 1 M NaOH for 2 h, washed sequentially with 1 M HC1 and methanol, treated ovemight with y-methacryloxypropyltrimethoxysilane (Sigma, St Louis, MO) and washed with methanol. The capillaries were then filled with a polymerizing solution of 6% acrylamide in TBE (89 mM Tris, 89 mM borate, 1 mM EDTA, pH 8.4), 0.1% TEMED and 0.025% ammonium persulfate, and left for several hours to polymerize.
Capillaries were filled with a fluid polyacrylamide matrix, which was replaced before each run. The matrix was prepared as follows: 5% acrylamide solution in TBE was deoxygenated by argon bubbling in an ice bath for 10 min and any contact of the solution with air was avoided until polymerization was complete. TEMED and ammonium persulfate were added to 0.03% and 0.003%, respectively. The polymerizing solution was immediately dispensed into 10 ml glass syringes and left at 2°C for several days. The matrix was dispensed from the 10 ml syringes into 100 high pressure U6K syringes (Rainin, Emeryville, CA) which were used to replace the matrix in capillaries through home-made teflon tube fittings.
About 108 total copies were electroinjected into a capillary and run at -200 V/cm. Samples were electroeluted from the anode end of the capillary into 0.5 mi Eppendorf tubes with 5111 of 0.1x TBE, 0.1 mg/ml bovine serum albumin. High resolution CDCE runs were performed at 100 V/cm using gel and running buffers containing 30 mM Na+ (30 mM sodium borate, pH 8), in addition to TBE. Gels for high resolution CDCE were prepared using a lower amount of ammonium persulfate (0.0015%). . The altered high melting domain primer used to generate CDGE markers was [alternate Crick strand primer(GAA GAA M TAT GGA GAA AGG GTG CGC CCG GGG GGA TAT AGG GTC GAA GC)]. The fluorescein moiety was linlced to a cyanoethyl phosphoramidite by a nine atom spacer arm. This species was coupled to the 5' end of the oligonucleotide during commercial synthesis (Ransom Hill Bioscience, Inc., Ramona, CA). The tetTamethylrhodamine (TMR) dye was coupled to the oligonucleotide via an amino C6 linker also during commercial synthesis (Biosynthesis, Louisville, TX). For asymmetrie pre-amplification, the conditions were the same as described above except the appropriate primer was omitted from the pre-amplification reaction mixture and exonuclease deficient Pfu polymerase (Stratagene, La Jolla, CA) was used instead of the exonuclease proficient form.
RESULTS AND DISCUSSION
Overview of the procedure
Our approach to measuring mutational spectra ( Fig. 1 ) is based on sequential enrichment of mutants that lie within a target sequence 100 bp long. The target sequence comprises the low melting domain of a 200 bp DNA fragment which has a biphasic melting profile suitable for separation of point mutants by partially denaturing gel electrophoresis, i.e. a low melting domain adjacent to a melting domain requiring a higher temperature for denaturation. Mutations in the low melting domain of such a sequence affect the rapid equilibrium between the partially denatured and double stranded forms of the molecule in a given temperature range, and therefore alter the mobility of the DNA through a gel matrix. The enrichment of mutants is based on separation of all of the mutant sequences present in a sample from the large excess of wild-type sequences.
Two separation methods were used, both of which are based on the principles of cooperative melting equilibria (27) : slab gel (CDGE) (28) and capillary (CDCE) (18) . Enrichment of mutants prior to subjecting the DNA to PCR was essential for low frequency mutant detection. CDGE was used as the pre-PCR enrichment step in order to permit separations of samples containing jtg amounts of total DNA. Such samples cannot be conveniently separated on capillaries with 75 inner diameter. CDCE, which permits rapid and precise collection of mutants, was used for post-PCR mutant enrichment.
Prior to CDGE separation, DNA was digested with a pair of restriction endonucleases that excise the 200 bp target fragment. The samples were doped with small known fractions of particular mutants which served as intemal standards. The intemal standards allow us to monitor the efficiency of enrichment at each step, and to determine the absolute mutant fractions of other mutants in a sample. The samples were run on CDGE, and mutant-enriched DNA fractions located above and below the wild-type were eluted. Enriched fractions were subjected to high fidelity PCR which eliminated interference from non-target DNA and also added a fluorescent label to the target sequence.
After PCR, the mutants were further enriched by CDCE separation. The pooled fraction containing all of the mutants, but not the wild-type DNA peak, was collected from the capillary and further amplified by PCR. Enriched samples in which mutants were clearly visible were run on high resolution CDCE capable of separating the mutants from each other and displaying them as individual peaks suitable for identification and isolation for sequencing. We now describe the key steps in more detail.
Copy number measurement
It is critical for measurement of mutant fractions in our samples that we accurately measure the number of copies of target sequence in each DNA sample. Since our measurements of mutant fractions are based on comparisons with intemal standards, knowledge of the total number of initial copies of the target sequence is essential for accurately introducing intemal standards at the desired initial fraction. Further, the number of mutant copies in the sample must be known to ensure that it is sufficient for the desired statistical power.
To measure the initial number of copies available for PCR in a DNA sample, the sample was doped with a PCR amplified target sequence containing a A:TG:C mutation at bp 10 072 to serve as an intemal standard. The number of mutant copies in the stock dilutions of intemal standard was inferred from the amount of primer used in PCR given that the primer was completely exhausted. The sample DNA and a known amount of intemal standard was subjected to PCR followed by CDCE. The areas of the wild-type and mutant peaks were determined. The ratio of these areas was used to calculate the initial number of copies.
Critical to this calculation is the demonstration that wild-type and intemal standard amplify with the same efficiency. The amplification efficiency of the internal standard was equal to that of the wild-type (0.6 per cycle) within ±1%. The error resulting from this slight efficiency inequality is smaller than the precision required in such an experiment. This method is robust; the sample can be doped at any ratio of mutant to wild-type from 0.01 to 100 with good results.
Pre-PCR enrichment by CDGE
Prior to enrichment for mutant sequences, samples are represented by -2.5 ig restriction digested cellular DNA containing -4 x 108 copies of the unlabeled target sequence. The small fraction of target sequences that bear mutations must now be separated from the vast excess of wild-type sequences and non-target DNA. This task could be simplified by PCR amplification of the sample followed by CDCE separation. However, to achieve low backgrounds and, hence, low detection limits, it is important to significantly enrich for mutants before PCR is applied to the sample.
Slab gel CDGE separation (28) was used for the necessary initial enrichment in the examples reported here. Under the partially denaturing conditions used for separation, 'high Tm mutants', i.e. mutants that increase the melting temperature of the target isomelting domain, have higher electrophoretic mobility than the wild-type fragments. Conversely, the mobility of low Tm mutants ' is lower than that of the wild-type. Therefore, by excising the portions of the gel below and above the wild-type band, one enriches for high and low Tm mutants, respectively. CDGE rather than CDCE was used at this stage because the large amount of non-target DNA and impurities in the samples create a high-resistance zone in the capillary which prevents separation. An altemative approach has since been developed, in which CDGE is replaced by CDCE in wide-bore capillaries (29) .
The efficiency of CDGE enrichment of mutants was estimated using a sample doped with a high Tm and a low Tm mutant as intemal standards at fractions of 10-2 each. Mutants at this fraction can be easily and reliably observed on CDCE after PCR. (The samples used for mutational analysis are usually doped at 10-5-10-4, fractions that are too low to be observed without enrichment). The ratio of mutant fraction after CDGE to the initial fraction represents the enrichment efficiency. The enrichment was typically 100-200 for high Tm mutants and 5-10 for low Tm mutants.
Elution from the CDGE gel slices and the first PCR represents the statistical 'bottleneck' in the procedure since the number of mutant copies is at a minimum. Any mutant to be measured with adequate precision (that is, not worse than ± 20%, 95% confidence limits) should be represented by at least 100 copies at the bottleneck in the procedure. Thus, if one began with 4 x 105 TK6 cells or 4 x 108 mitochondrial DNA copies, a mutant with a mutant fraction of 10-6 would be present as 400 copies. Losses in DNA isolation and enrichment steps would reduce this number to -200, and an estimated efficiency of the first cycle of PCR of 0.5 would mean the bottleneck number would be 100 mutant copies, the minimum necessary to give the desired lower limit of statistical uncertainty.
High-fidelity PCR
After enrichment by CDGE, the samples were subjected to PCR, which generated 1012 copies of the target sequence, reduced the relative amount of non-target DNA to an insignificant level and provided for fluorescent labeling of the target. In essence, PCR made the samples suitable for convenient CDCE separations.
During PCR, the mutants were converted into heteroduplexes with the excess of wild-type strands by continuing to subject the sample to temperature cycles even after the point where the primers were exhausted. All such heteroduplexes have significantly lower melting temperatures than the parent wild-type homoduplex, a fact which allows collection of all of the heterodouplexes as a single fraction greatly reduced in the number of wild-type strands by DGGE, CDGE or CDCE (30) .
PCR introduces `noise' into the analysis. It is important to amplify with a DNA polymerase of sufficiently high fidelity so that errors created by copying excess wild-type strands do not interfere with observation of mutants in the samples (31) . Pfu polymerase was used in this work because it is thermostable and has high fidelity, with an error rate as low as 2 x 10-6 errors per base per doubling (32) . In our target sequence the rate appears to be even lower, 7 x 10-7 (André et al., in preparation). This is significantly lower than all other DNA polymerases we have screened for fidelity. On the other hand, Pfu shares with other DNA polymerases the ability to convert wild-type sequences into byproducts that have lower melting temperatures than the wild-type homoduplex. These byproducts can interfere with the mutant enrichment step on CDCE. Among these byproducts are incomplete or exonucleolytically processed products missing from one to several nucleotides. We have experienced fractions of these byproducts as high as 50% of the total in some PCR preparations. The problem has been reduced but not eliminated by use of an increased Pfu concentration (4-fold higher than the manufacturer 's suggestion) and a 30 min post-PCR incubation at 45°C. Under these conditions the CDCE enrichment is -30-fold, limited by collection of 3% of the wild-type as tail on the main peak and low melting temperature wild-type byproducts.
Post-PCR enrichment by CDCE
A post-PCR CDCE separation is shown in Figure 2A . with initial fractions of -4 x 10-4 and 3 x 10-4 was chosen for demonstration purposes. The four heteroduplexes of the two mutants (marked by Xs) are -0.2% of the wild-type peak (which implies 5-fold CDGE enrichment) and are hardly distinguishable among the wild-type variants (noise) which are present at a similar fraction (marked by asterisks). The heteroduplex fraction of the first CDCE was collected, amplified and run on a second CDCE (Fig. 2B) . Now the four heteroduplex peaks of the two major mutants are clearly visible above the background and constitute >5% of the wild-type peak each, which implies a >25-fold enrichment by CDCE. In addition to these prominent peaks, smaller mutant peaks that were not visible on the first CDCE can be seen on the second CDCE.
The combined size of all mutant heteroduplex peaks in the separation shown in Figure 2B is comparable to the size of the wild-type peak. In this situation, another collection of the heteroduplex fraction will not significantly enrich against the wild-type because each heteroduplex contains one wild-type strand. If the initial frequency of mutants in the sample were lower, as is usually the case, the combined size of heteroduplexes at this stage would be smaller and additional CDCE separations would provide further enrichment.
High resolution CDCE
Once the mutants have been enriched, our goal is to separate, measure, isolate and sequence the individual mutants. We convert mutant heteroduplexes into homoduplexes by stopping PCR when the molar amount of unused primers still exceeds that of the products.
Homoduplexes are then separated via CDCE under high resolution separation conditions' that include increasing the length of the zone, decreasing the running voltage, and increasing the salt concentration in the electrophoretic buffer. As we show in a recent paper (33) , the improvement in resolution with these modifications results from increasing the average number of partial meltings and reannealings a molecule undergoes while in the heated zone of the capillary. Figure 3 (upper curve) shows a high resolution separation of the same sample as the one shown in Figure 2B after it was converted to homoduplex form. The reason that the two separations look dissimilar is that each pair of heteroduplexes present in Figure 2B yielded a single homoduplex peak in Figure 3A .
Identification of mutants
In our first studies of mitochondrial hotspot mutants, each mutant peak was isolated, amplified and sequenced. It became clear soon thereafter that the same mutants appeared in multiple samples and that a more efficient mode of mutant identification was possible. All sequenced mutants were labeled with tetramethylrhodamine (TMR) and combined together to form a standard set' of markers. This 'TMR-labeled 'standard set' could then be coinjected with an aliquot of fluorescein-labeled sample under study and both signals could be observed on a single CDCE separation by means of a two-wavelength detector. In this way, mutants in the fluorescein-labeled sample could be identified based on comigration with the rhodamine-labeled previously isolated hotspot mutants. Further, any novel mutants could be identified for subsequent isolation and sequencing. This time saving approach is illustrated in Figure 3 .
Comigration of an unknown peak with a known standard is not proof of identity (non-comigration is proof of nonidentity). Two different mutants could potentially co-migrate leading to false identification. In order to provide a more rigorous test of peak identity, we developed an identification procedure based on on-column hybridization of sample peaks with the mutants of the standard set (in preparation). The CDCE instrument used for identification by hybridization included two consecutive heating jackets. The sample and the standards were co-separated in the first jacket as for identification by co-migration and the resulting set of peaks was stoppecl inside the second jacket. The temperature in the second jacket was increased to denature the DNA, then decreased to permit reannealing of single strands, and fmally the sample was electrophoresed through the rest of the second jacket to the detector. If a peak of the sample was not identical to the standard mutant with which it co-migrated during the pre-hybridization part of CDCE separation, such hybridization converted the sample mutant into two heteroduplexes with the standard mutant present in excess. Such heteroduptexes are always fess stable than the homoduplexes from which they were derived, and they moved to a different position during the post-hybridization portion of CDCE separation. This resulted in the `disappearance' of the sample peak from the spectrum. This approach is as precise as sequencing but does not require isolation of individual mutants prior to identification. The identities of all the mutant peaks reported in this paper were verified either by direct sequencing or on-column hybridization.
Quantification of mutants
The area under each peak in Figure 3 is proportional to the initial mutant fraction in this sample. The initial mutant fraction of mutant peaks p3, p1.5 and pl can be determined by comparison of the areas under these peaks to the peak representing the 10-4 intemal standard. In this sample, the original fractions of mutants represented by p3, p1.5 and pl are estimated to be 5 x 10-5, 4 x 10-'4 and 3 x 10-4, respectively.
Given that our procedure involves -109-fold amplification, the relative sizes of the peaks we observe may depend not only on the original mutant fractions but also on the relative amplification advantage or disadvantage of a particular mutant (aflek preference). To discover if the mutant fractions we report deviatecl significantly from the original fractions due to allelic preference, we checked the relative amplification efficiencies of most of the mutants in the standard set. Mutants were mixed together and amplified 1000-fold in the same PCR reaction and the relative sizes of the peaks before and after the amplification were compared, as suggested by Keohavong and Thilly (31) . The amplification efficiency of the mutants was within ±6% of the efficiency of amplification of the wild-type (0.6 per cycle). Given that the overall amplification of mutants during our procedure is -109-fold, these differences in amplification efficiencies will lead to errors in the measurement of mutants within a factor of two. These errors may be corrected by the appropriate weighting of the mutant frequencies as determined by comparison with the internal standards.
Since it is not possible to check the amplification efficiencies of all theoretically possible mutants, we cannot exclude the possibility that some mutants with a severe amplification disadvantage were originally present in the samples but were missed dwing our isolation procedure. 
Limit of detection: reconstruction experiments
We determined the limit of detection of this method by doping purified wild-type sequences with purified mutants of known quantity. Shown in Figure 4A are the results when wild-type PCR fragments purified from possible mutants by CDGE were doped with a low Tm mutant at 10-4 and with a high Tm mutant at 10-5, mixed with non-amplifiable herring carrier DNA, and subjected to all the procedures described above except for the initial DNA isolation. The data sets are separated as 'high Tm mutants ' and low Tm mutants' because they are processed separately at stages succeeding CDGE. When such a sample is enriched in mutants by CDGE, the peaks representing both of the reference mutants are about 10 times larger than the largest peaks of the background (Fig. 4A) . Thus, the limit of detection, defined as the frequency of a mutant that yields a peak comparable to the largest background peaks, should be considered 10-5 for low Tm mutants and 10-6 for high Tm mutants. When CDGE enrichment is not used, as may be seen in Figure 4B , the background noise is 5-10-fold higher than when it is used. Comparison of Figure 4A and B therefore demonstrates that the CDGE step improves the limit of detection of the method -10-fold, from 10-5 to 10-6 for high Tm mutants and from 10-4 to 10-5 for low Tm mutants, thus illustrating the need for a CDGE enrichment step prior to PCR.
Since the limit of detection depends on the size of background peaks, it is important to know the sourc,es of background mutants. Most of the background peaks do not co-migrate with mutants originating from Pfu replication errors (André et al., manuscript in preparation). We therefore assume that the background mutations most probably arose from mutagenic DNA lesions that were generated during our procedures. The difference in detection limits between high and low Tm mutants could iefiect that more of these lesions co-migrate with low Tm mutants than with high Tm mutants.
Examples of mutational spectra in human cells and muscle tissue
The approach described herein was tested by measuring mutational spectra of cultured cell populations and human tissue samples. Shown in Figure 5B are high resolution CDCE runs of a sample derived from a culture of TK6 cells, while Figure 5C shows the same data for a sample of human bronchial epithelial cells. Figure 5A shows the outcome of subjecting CDGE-purified mitochondrial wild-type homoduplexes to the procedure as a negative control for the entire analytical cascade.
The cell and tissue samples contain a series of peaks that are not present in the negative control (Fig. 5A) . The fractions of high Tm mutants in the TK6 sample (Fig. 5B) are on the order of 10-6. On the contrary, the low Tm' mutants are as high as 4 x 10-4. The labeled peaks are the internal standard, a G:CA:T transition at mt bp 10 040, and G:C->A:T transitions at bp 10 038 (p3), 10 068 (p 1 ) and 10 085 (p1.5). The unlabeled peaks have not been identified yet.
The bronchial epithelium sample (Fig. 5C ) displays significant peaks in both the high and low Tm sets. In the low Tm set, the bronchial tissue displays some of the same hotspot mutants as are found in the TK6 cells (Pl and p3). In the high Tm region of the bronchial epithelium sample, several peaks are seen with mutant fractions on the order of 10-4. Five peaks are identified as A:T->G:C transitions at bp 10 057 (pil), 10 058 (p115), 10 060 (p113), 10 066 (p18) and 10 071 (p16). 
Sources of experimental error
There are two classes of errors which could potentially `create' some of the mutants we observe. The first class involves artefacts generated by our procedures themselves. Contamination of samples and PCR-created mutants are included in this first class. PCR errors could arise as misincorporation events dwing primer extension over a wild-type substrate or as a result of replicative bypass of DNA adducts formed in our procedures. The errors of this class are readily detectecl by comparison of a spectrum to the negative control, such as the one shown in Figure 5A . The errors of a second class arise when cellular mutagenic sites are converted into mutants by our procedures. These would include DNA adducts in the original mitochondrial sample that were bypassed by the polymerase during PCR to create mutants. Similarly, mismatch intermediates that were formed during DNA replication but were not yet repaired at the time of DNA isolation, would be mistaken for true heritable mutations. The errors of this class can be detected based on the fact that the mutagenic sites are associated with only one of the two DNA-strands.
Errors arising during mutant isolation procedure
The mutants that we detect with this method are represented in our initial samples by as few as 400 molecules. Consequently, an obvious problem is the potential for contamination from purified PCR preparations of these mutant sequences. Although there are a number of ways to reduce the probability of such accidents, we have chosen the alternative of setting up a clean laboratory equipped with high-throughput air filters. No PCR products of purified mutant sequences are allowed into this laboratory except for very dilute stocks used to introduce internal standards. DNA isolation, CDGE, and preparing aliquots for PCR are performed in this laboratory. Our quality control procedures involve routine negative controls which have shown no evidence of contamination in the past few years, but which did detect intermittent contamination in earlier studies.
In order to determine whether any of the mutant peaks were caused either by Pfu polymerization errors or by replicative bypass of DNA adducts created during our procedures, we subjected CDGE-purified wild-type homoduplex containing appropriate internal standards to all of the steps of our procedure. The background peaks observed (Fig. 5A) were much smaller than the mutant peaks isolated from cellular DNA (Fig. 5B and  C) . This demonstrates that the background generated by our procedure is small enough not to interfere with real cellular mutants. In a variation on this control, to test whether detectable levels of DNA adducts leading to noise `mutants' were generated during cell lysis, we mixed the purified target human mitochondrial fragment with rat cells and carried out the entire procedure. No interfering signals were obtained in this control experiment either.
Errors arising from cellular mutagenic lesions and mismatches
Two additional sources of false mutants are potentially mutagenic lesions of cellular (as opposed to instrumental) origin which yield mutants when bypassed by a polymerase during PCR, and replication mismatches not yet repaired at the time of DNA isolation. These two types of errors cannot be recognized by any of the tests described above. In order to discriminate cellular lesions and mismatches from true mutants, we developed a method that exploits a distinguishing property of these species: adducts or sequence changes are present in only one of the two DNA strands, while the other strand is an unadducted wild-type sequence. True mutants, in contrast, contain a changed sequence at the same base pair in both DNA strands of the original sample.
To preserve this distinguishing information, we developed a modified PCR procedure which includes asymmetrie pre-amplification. Two aliquots of a CDGE-enriched sample are subjected to repeated primer elongation cycles with only one or the other of the two PCR primers. During this linear amplification' stage, only one strand of the sample DNA is used as a template. Thus after preamplification one aliquot will contain a vast excess of 'Watson' copies while the other will contain excess `Crick' copies as single stands Then the other primer is added and exponential amplification proceeds.
Asymmetrie pre-amplification of a real double stranded mutant results in equal fractions of a particular mutant when the opposite DNA strands are compared. However, in the case of a mismatch or a pre-mutagenic lesion, the mutant will arise only from copying the strand which contains the mismatch or premutagenic lesion. This results in an asymmetric distribution of the mutant between the spectra obtained from the two aliquots which begin by copying only the Watson or the Crick strand. Figure 6 shows the results of asymmetric pre-amplification as applied to low Tm mutants isolated from a lung epithelium sample from a different person than that shown in Figure 4C . The sample contains the peaks for pl (G:C->A:T at bp 10 068) and p3 (G:C->A:T at bp 10 038). The results show that pl yields the same mutant fraction regardless of the strand used in linear amplification. We regard this as strong evidence that this signal arises from a true mutant in this sample. However, the signal designated p3 shows a significantly larger mutant fraction when linear amplification copies the Watson as opposed to the Crick strand. These results suggest that a significant portion of the signal designated p3 arose either as a mismatch intermediate or as an adduct located in the Watson strand that was converted into a mutant by Pfu polymerase. Another mutant, yet unsequenced peak designated X in Figure 6 , demonstrates the opposite distribution, which suggests that it originates in significant part from a mismatch or a lesion located on the Crick strand. As a rule, high Tm mutants behaved symmetrically in the assay. The signal represented by peak p3, however, has behaved asymmetrically in all samples analyzed to date, while the signal represented as peak Pl showed different degrees of asymmetry in different samples.
